<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-FT.CE.107.FE.1.24SQ</udiDi>
    <basicUdiDi>B-FT.CE.107.FE.1.24SQ</basicUdiDi>
    <tradeName>REFLUCALM</tradeName>
    <deviceName>REFLUCALM</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FE.1.24</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:03:05.441Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FE.1.2103C</udiDi>
    <basicUdiDi>B-FT.CE.107.FE.1.2103C</basicUdiDi>
    <tradeName>REFLUCALM</tradeName>
    <deviceName>REFLUCALM</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FE.1.210</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:03:03.823Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FE.1.210.A3M</udiDi>
    <basicUdiDi>B-FT.CE.107.FE.1.210.A3M</basicUdiDi>
    <tradeName>REFLUCALM</tradeName>
    <deviceName>REFLUCALM</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FE.1.210.APPLE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:58.492Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FE.1.12SH</udiDi>
    <basicUdiDi>B-FT.CE.107.FE.1.12SH</basicUdiDi>
    <tradeName>REFLUCALM</tradeName>
    <deviceName>REFLUCALM</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FE.1.12</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:58.463Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FE.1.12.AEQ</udiDi>
    <basicUdiDi>B-FT.CE.107.FE.1.12.AEQ</basicUdiDi>
    <tradeName>REFLUCALM</tradeName>
    <deviceName>REFLUCALM</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FE.1.12.APPLE</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:57.648Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FD.8.CAMPSM</udiDi>
    <basicUdiDi>B-FT.CE.107.FD.8.CAMPSM</basicUdiDi>
    <tradeName>REFLUCALM PLUS L</tradeName>
    <deviceName>REFLUCALM PLUS L</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FD.8.CAMP</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:55.452Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FD.8.3005A</udiDi>
    <basicUdiDi>B-FT.CE.107.FD.8.3005A</basicUdiDi>
    <tradeName>REFLUCALM PLUS L</tradeName>
    <deviceName>REFLUCALM PLUS L</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FD.8.300</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:51.442Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FD.8.24TU</udiDi>
    <basicUdiDi>B-FT.CE.107.FD.8.24TU</basicUdiDi>
    <tradeName>REFLUCALM PLUS L</tradeName>
    <deviceName>REFLUCALM PLUS L</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FD.8.24</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:50.892Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FD.8.21058</udiDi>
    <basicUdiDi>B-FT.CE.107.FD.8.21058</basicUdiDi>
    <tradeName>REFLUCALM PLUS L</tradeName>
    <deviceName>REFLUCALM PLUS L</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FD.8.210</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:49.609Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.107.FD.8.12TM</udiDi>
    <basicUdiDi>B-FT.CE.107.FD.8.12TM</basicUdiDi>
    <tradeName>REFLUCALM PLUS L</tradeName>
    <deviceName>REFLUCALM PLUS L</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.107.FD.8.12</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:02:47.646Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303151223</udiDi>
    <basicUdiDi>B-04035303151223</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PLUS 10 Sachets</tradeName>
    <deviceName>TOXAPREVENT MEDI PLUS 10 Sachets</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11201019</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:44.387Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303151216</udiDi>
    <basicUdiDi>B-04035303151216</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PLUS 30 Sachets</tradeName>
    <deviceName>TOXAPREVENT MEDI PLUS 30 Sachets</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11201017</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:43.592Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303151209</udiDi>
    <basicUdiDi>B-04035303151209</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PURE 60 Capsules</tradeName>
    <deviceName>TOXAPREVENT MEDI PURE 60 Capsules</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11201018</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:39.985Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303151193</udiDi>
    <basicUdiDi>B-04035303151193</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PURE 180 Capsules</tradeName>
    <deviceName>TOXAPREVENT MEDI PURE 180 Capsules</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11201016</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:39.982Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303130174</udiDi>
    <basicUdiDi>B-04035303130174</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PURE 60 Kapseln</tradeName>
    <deviceName>TOXAPREVENT MEDI PURE 60 Kapseln</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11001052</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:39.968Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303130181</udiDi>
    <basicUdiDi>B-04035303130181</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PLUS 10 Sticks</tradeName>
    <deviceName>TOXAPREVENT MEDI PLUS 10 Sticks</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11001053</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:39.944Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303130150</udiDi>
    <basicUdiDi>B-04035303130150</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PLUS 30 Sticks</tradeName>
    <deviceName>TOXAPREVENT MEDI PLUS 30 Sticks</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11001051</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:33.186Z</lastUpdated>
  </row>
  <row>
    <udiDi>04035303130143</udiDi>
    <basicUdiDi>B-04035303130143</basicUdiDi>
    <tradeName>TOXAPREVENT MEDI PURE 180 Kapslen</tradeName>
    <deviceName>TOXAPREVENT MEDI PURE 180 Kapseln</deviceName>
    <manufacturerName>FROXIMUN AG</manufacturerName>
    <manufacturerSrn>DE-MF-000014501</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11001050</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-16T11:51:32.382Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055748841097</udiDi>
    <basicUdiDi>805574884FTKMDR14ET</basicUdiDi>
    <tradeName>Comil viet</tradeName>
    <deviceName>COMIL</deviceName>
    <manufacturerName>Gruppo Farmaimpresa srl</manufacturerName>
    <manufacturerSrn>IT-PR-000036632</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>FT.K.MDR.14.3.CAP.VIET</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T09:03:07.325Z</lastUpdated>
  </row>
  <row>
    <udiDi>04251778108191</udiDi>
    <basicUdiDi>42517781MD347D7</basicUdiDi>
    <tradeName>DulcoSoft Constipation</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HÄLSA Pharma GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007407</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>777371</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-16T06:10:09.781Z</lastUpdated>
  </row>
</eudamedExport>